Predictors of clinical response to erenumab in patients with migraine
Background: Anti-CGRP monoclonal antibodies have emerged as efficacious preventive therapies for some, but not all patients with migraine. It is not yet fully understood what predicts treatment response. Objective: To identify factors associated with good or poor response to erenumab, the first avai...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
SAGE Publishing,
2022-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|